Hormone Induction of Progesterone Receptor (PR) Messenger Ribonucleic Acid and Activation of PR Promoter Regions in Ovarian Granulosa Cells: Evidence for a Role of Cyclic Adenosine 3',5'-Monophosphate but Not Estradiol
Jeffrey W. Clemens1,
Rebecca L. Robker,
W. Lee Kraus2,
Benita S. Katzenellenbogen and
JoAnne S. Richards
Department of Cell Biology (J.W.C., R.L.R., J.S.R.) Baylor
College of Medicine Houston, Texas 77030
Department of
Molecular and Integrative Physiology (W.L.K., B.S.K.) University of
Illinois Urbana, Illinois 61801
 |
ABSTRACT
|
---|
Expression of progesterone receptor (PR) mRNA in
granulosa cells of ovarian preovulatory follicles is induced by LH (1,
2) and is essential for ovulation (3). Although 17ß-estradiol (E) can
induce PR mRNA and activate PR promoter-reporter constructs in other
cell types, the effects of E in granulosa cells appear to be indirect.
We show herein that E alone does not induce the expression of PR mRNA
in preovulatory granulosa cells. Rather, induction of PR mRNA depends
on the differentiation of granulosa cells in response to E and a
physiological amount of FSH followed by exposure to agonists (elevated
levels of LH, FSH, and forskolin) that markedly increase cAMP.
Induction of PR mRNA by forskolin is blocked by the A-kinase inhibitor
H89 and cycloheximide but not by the E antagonist, ICI 164,384. These
results indicate that phosphorylation and synthesis of some regulatory
factor(s) other than or in addition to the estrogen receptor (ER) are
essential for transactivation of the PR gene. When distal and proximal
PR promoter-reporter constructs that are responsive to E in other
cell types were transiently transfected into differentiated granulosa
cells, forskolin, but not E, induced activity. Likewise, when a vector
containing the consensus vitellogenin B1 gene estrogen response element
(ERE) was transfected into differentiated granulosa cells, forskolin,
but not E, induced activity. Using electrophoretic mobility shift
assays, the consensus ERE was shown to bind ERß, the predominant
subtype present in rat granulosa cells, and ER
, the predominant
subtype present in luteal cells, whereas the putative ERE-like region
(ERE3) of the proximal PR promoter did not bind either ER subtype.
Although the identity of the specific factors binding to the ERE3 site
remain to be determined, mutation of this region abolished
forskolin-induced activity of ERE3-PR-CAT constructs. The GC-rich
region of the distal PR promoter bound Sp1 and Sp3 but not
C/EBP
/ß, indicating that factors binding to ERE3 interact
synergistically with Sp1/Sp3 to confer increased responsiveness of the
distal promoter to forskolin. Taken together, these results indicate
that activation of the A-kinase pathway leads to the
phosphorylation of some transcription factor(s) other than or in
addition to ER that is (are) critical for the transactivation of the PR
gene and that this mechanism is selectively activated in differentiated
granulosa cells possessing a preovulatory phenotype.
 |
INTRODUCTION
|
---|
The surge of LH is the physiological trigger that stimulates
ovulation, a process by which preovulatory follicles rupture and
release a fertilizable oocyte. Recent studies have shown that the LH
surge induces in granulosa cells of these preovulatory follicles the
rapid and transient expression of specific genes critical for the
ovulation process (4). One of these genes encodes the progesterone
receptor [PR (1, 2, 3, 4, 5)] which is a member of the nuclear receptor
superfamily of transcription factors.
PR mRNA is selectively induced in granulosa cells of preovulatory
follicles within 57 h of the LH surge (1, 2, 6) and is localized to
nuclei of preovulatory granulosa cells exposed to ovulatory
concentrations of LH in culture (2). PR mRNAs expressed in granulosa
cells encode both the short (PRA) and long
(PRB) forms of the receptor (2), which are derived from two
internal ATG translational start sites within the first exon (7, 8, 9, 10).
Because these two receptor proteins differ in the N-terminal
transactivation domain, their relative functional activities in various
target cells may differ (11, 12). In target tissues such as the uterus,
mammary gland, and hypothalamic-pituitary cells, progesterone
activation of its receptor leads to the transcription of numerous genes
(13). In the ovary, target genes for PR action have not yet been
identified. However, targeted deletion of the PR gene in mice causes a
mouse phenotype with numerous reproductive abnormalities (3). One of
the defects in PR-/- mice is the failure to ovulate even when
exogenous gonadotropins are administered (3). The anovulatory phenotype
of these PR-/- mice confirms many earlier studies that indicated a
key role for progesterone (Refs. 2, 14, 15 for review) and the increase
in PR (1, 2) in the LH-induced process of ovulation.
The regulated expression of the PR gene in different tissues, including
the ovary, is complex and appears to depend, in part, on the structure
of the PR gene. The rat and mouse PR cDNAs (7, 16) and the rat, human,
and rabbit PR genes (7, 8, 9, 10) have been cloned. Within the 5'-flanking
region, two putative functional promoters have been described. The
distal promoter (P) resides at -131/+65 bp in the rat 5'-flanking
sequence, and the proximal promoter (P') resides at +461/+675 bp within
the 5'-untranslated region (7). The distal and proximal promoters have
putative binding sites for the estrogen receptor (ER), designated
estrogen response element (ERE)-like regions (7, 10). The
proximal promoter also contains an ERE1/2 site (7, 10). Functional
studies of these two promoters in different nonovarian cell types
indicate that the proximal promoter responds to 17ß-estradiol (E),
whereas the distal promoter does not unless two or more copies of the
PR promoter ERE-like sequences or a consensus ERE (17) are ligated to
it (7, 10). Furthermore, the inducibility of these promoters by E
differs in different cell types, presumably due to different levels of
endogenous ER, the subtype of ER (ER
vs. ERß) or
specific coactivators present in the different cells (7, 10).
In addition to ligand-dependent activation of ER, it is becoming
increasing clear that phosphorylation can enhance receptor activation
in the presence of ligand or even activate the receptor in the absence
of ligand (18, 19). Different kinase cascades also activate ER at
different positions in the molecule; epidermal growth factor through
the N-terminal AF1 region and A-kinase through the C-terminal AF2
region (20). With regard to the induction of PR, cAMP stimulation of
the A-kinase pathway has been documented to enhance the effects of E in
other tissues (Ref. 7 and references therein) and to directly activate
the distal promoter activity in ovarian cells (21). However, the
precise mechanisms by which E and cAMP coordinately regulate the
expression of PR in different tissues remains unclear. They may either
lead to the induction and phosphorylation of ER, or other factors that
bind selectively to the distal promoter (21), or specific coregulatory
molecules (22, 23). In the ovary, there is an additional enigma.
Granulosa cells of preantral and preovulatory follicles express
nuclear E-binding proteins (24). Based on in situ
hybridization, these are now known to be comprised predominantly of
ERß with lesser amounts of ER
(25, 26). E is synthesized at high
levels in granulosa cells of preovulatory follicles before the LH
surge. However, PR mRNA and protein are only expressed in preovulatory
granulosa cells that have been exposed to the LH surge. Thus, it is
critical to determine the mechanisms by which ER and activation of the
A-kinase pathway lead to transactivation of the PR gene in granulosa
cells.
Based on precise temporal induction of PR mRNA and protein by the LH
surge and the obligatory role of PR in ovulation, we have sought
to determine whether E is necessary for LH induction of PR in the
preovulatory follicle and if it directly mediates transactivation of
the PR promoter. For this we have analyzed 1) the temporal requirement
of E, FSH, and LH for induction of PR mRNA, 2) regions of the PR
promoter that are required for activation by ER and/or the A-kinase
pathway, and 3) factors that bind to putative regulatory regions of the
distal and proximal promoters of the PR gene.
 |
RESULTS
|
---|
E Alone Does Not Induce PR mRNA in Granulosa Cells
The temporal effects of E, FSH, and LH on the induction of PR mRNA
were analyzed in primary rat granulosa cell cultures. Granulosa cells
were harvested from immature rats (27, 28), plated in serum-coated
dishes, and cultured in chemically defined medium with either E (10
ng/ml) or testosterone (T; 10 ng/ml) alone for 48 h. Additional
cells were cultured for 48 h with T and FSH (50 ng/ml), a
treatment known to stimulate the differentiation of these cells to a
preovulatory phenotype (4, 27, 28). Forskolin (10 µM), a
direct activator of adenylyl cyclase, was added to the cultures at
48 h to stimulate the acute increase in cAMP (Fig. 1A
). Neither T nor E alone increased PR
mRNA. When forskolin was added to the cells cultured with E or T alone,
this cAMP-stimulatory agonist was unable to induce the rapid
appearance of PR mRNA. However, in the differentiated, FSH/T-treated
granulosa cells, forskolin induced a marked increase in PR mRNA within
5 h (4853 h) (P < 0.001; Fig. 1A
). These
results confirm earlier studies in cycling rats (1) and in granulosa
cell cultures (2), showing that FSH is critical for granulosa cell
differentiation and subsequent responses to cAMP, and provide the
additional, novel information that neither E nor T alone induces PR
mRNA in granulosa cells or permits the acute induction of PR mRNA by
forskolin.

View larger version (25K):
[in this window]
[in a new window]
|
Figure 1. Induction of PR by Forskolin Requires Granulosa
Cell Differentiation
A, Neither E nor T alone can induce PR in granulosa cells. Granulosa
cells were isolated from untreated, immature rats and cultured in
serum-free medium for 48 h in the presence of either T (10 ng/ml),
E (10 ng/ml) or T and FSH (50 ng/ml) (FSH/T). Forskolin (10
µM) was added to the cultures and RNA isolated 5 h
later (4853 h). PR mRNA was analyzed in this and subsequent figures
by RT-PCR as described in Materials and Methods and
expressed relative to mRNA for the ribosomal protein L19. B, The E
antagonist ICI 164,384 does not block the acute induction of PR mRNA by
forskolin. Granulosa cells from untreated, immature rats were cultured
for 48 h in the presence of FSH and T (10 ng/ml) or with FSH, T,
and ICI 164,384 (500-fold molar excess relative to T). At 48 h,
cells in each group were either processed immediately for RNA or
exposed to forskolin (10 µM) for an additional 5 h
(4853 h). Additional cells were cultured with FSH/T for 48 h,
exposed to both forskolin and ICI for 5 h, and RNA was prepared.
PR mRNA was analyzed by RT-PCR.
|
|
To determine whether the effects of E and its receptor are mediated
indirectly at some earlier stage of granulosa cell differentiation, the
ER antagonist ICI 164,384 (ICI) was added at two different times during
cell culture. The effects of E during granulosa cell differentiation
were analyzed by adding ICI simultaneously with FSH and T at the
initiation of the culture. The effects of E and ER on the acute
induction of PR mRNA by forskolin were determined by adding ICI to the
FSH/T-treated cells at the same time as the addition of forskolin
(i.e. at 48 h of culture). As shown in Fig. 1B
, administration of ICI at the initiation of culture severely reduced (by
60%; P < 0.001) the subsequent induction of PR by
forskolin. In contrast, when ICI was added to the differentiated cells
together with forskolin (at 48 h), ICI failed to block the
induction of PR mRNA by the A-kinase activator. These results indicate
that E and ER mediate specific effects on granulosa cell
differentiation but are not obligatory for the rapid induction of PR by
cAMP and A-kinase. To determine more precisely when addition of E to
the granulosa cell cultures is needed to facilitate the
induction of PR mRNA by forskolin, granulosa cells were cultured in the
continuous presence of FSH with E added at selected time intervals. As
controls, T and E were added at the initiation of culture (Fig. 2
; t = 0, left and
right panels, respectively). E was also added after 6
(t = 6), 12 (t = 12), or 24 (t = 24) h of culture (Fig. 2
; right panels). The induction of PR mRNA by forskolin
(P < 0.001; solid bars) was similar in all
cultures. These results show that when granulosa cells are cultured
with E, the steroid acts synergistically with FSH even when added as
late as 2448 h of culture.

View larger version (16K):
[in this window]
[in a new window]
|
Figure 2. Induction of PR by Forskolin Requires FSH and a
Time-Dependent Exposure of Cells to E
Granulosa cells of untreated, immature rats were cultured in the
presence of FSH for 48 h with T or with E added at the initiation
of culture (t = 0) or at 6, 12, and 24 h after plating. At
48 h, cells were left untreated (open bars) or
exposed to forskolin (10 µM; solid bars).
RNA was isolated from all cells 5 h later.
|
|
Induction of PR mRNA Is Dependent on Granulosa Cell
Differentiation
We next determined the time and dose-dependent effects of FSH for
induction of PR mRNA by forskolin. Granulosa cells were either cultured
for 48 h in the absence of hormones or in the presence of T (10
ng/ml) and a physiological level of FSH (50/ng/ml). T and the
physiological dose of FSH are known to induce a preovulatory phenotype
in which granulosa cells express aromatase (28) and LH receptor (29)
and respond to LH with induction of specific genes such as PGS-2 (30)
and C/EBPß (31). When granulosa cells were cultured for 48 h in
the absence of hormones, neither ovulatory concentrations of FSH [500
ng/ml (30)], GnRH [1 µM (31)] or high levels of
forskolin [10 µM (4)] induced PR mRNA (Fig. 3A
). When cells were cultured with T and
a low level of FSH (10 ng/ml), a progressive 5-fold increase in PR mRNA
occurred in response to increasing concentrations of LH (Fig. 3B
). In
contrast, cells cultured with T and a physiological concentration of
FSH (50 ng/ml) responded vigorously to increasing concentrations of LH.
Levels of PR mRNA in these cells were 8-fold higher than in the cells
cultured with low levels of FSH and T at 5.0 ng/ml LH (Fig. 3B
, left panel). Furthermore, the maximal response observed in
these differentiated cells cultured with physiological amounts of FSH
occurred in response to as little as 2.5 ng/ml LH, a dose 200 times
less than that used previously (Fig. 3
, A and B, and Ref. 2). These
preovulatory granulosa cells also exhibited a marked response to FSH
and GnRH, as well as to the phorbol ester PMA (phorbol myristate) (Fig. 3A
). These results indicate that the differentiated cells exhibit an
enhanced response to the A-kinase activators (FSH/LH) and C-kinase
activators (GnRH/PMA).

View larger version (32K):
[in this window]
[in a new window]
|
Figure 3. Induction of PR by Various Agonists Is Dependent on
Steroid and a Physiological Dose of FSH
A, Granulosa cells were isolated from E-primed, immature rats and
cultured for 48 h in medium alone or in the presence of FSH (50
ng/ml) and T (10 ng/ml). At 48 h, ovulatory doses of FSH (500
ng/ml) and LH (500 ng/ml) or high concentrations of forskolin (10
µM), GnRH (1 µM), or PMA (100 ng/ml) were
added to the cultures for 5 h. RNA was isolated 5 h later; PR
mRNA was quantified by RT-PCR. B, Granulosa cells were cultured as
above with either low levels of FSH (10 ng/ml) or physiological amounts
of FSH (50 ng/ml). At 48 h, increasing concentrations of LH were
added, RNA was isolated 5 h later, and PR mRNA was analyzed by
RT-PCR.
|
|
To determine whether A-kinase and C-kinase pathways were being
selectively activated by LH, the A-kinase and C-kinase inhibitors, H89
and Calphostin C, respectively, were used. For these experiments
granulosa cells were cultured for 48 h in the presence of FSH (50
ng/ml) and T (10 ng/ml). At 48 h of culture, the cells were
challenged with forskolin without or with the addition of H89 (added
1 h before [t = -1] or at the same time [t = 0] as
forskolin) or Calphostin C. H89 at either time completely inhibited
(P < 0.001) the induction of PR mRNA, whereas
addition of Calphostin C had much less of an effect (P
< 0.02; Fig. 4
). The induction of PR
mRNA by the A-kinase pathway appears to involve de novo
protein synthesis since the addition of cycloheximide also
abolished the induction by forskolin (P < 0.001; Fig. 4
). From these data we conclude that activation of the C-kinase pathway
can induce expression of PR. However, activation of the A-kinase (not
C-kinase) pathway and de novo protein synthesis are
essential for LH-mediated induction of PR mRNA.

View larger version (32K):
[in this window]
[in a new window]
|
Figure 4. Induction of PR by Forskolin Depends on Activation
of the A-Kinase Pathway and a Cycloheximide-Sensitive Factor
Granulosa cells were harvested from E-primed, immature rats and
cultured 48 h with FSH/T as described in Fig. 3A . The A-kinase
inhibitor, H89 (10 µM), and the protein synthesis
blocker, cycloheximide (CHX; 10 µg/ml), were added either 1 h
before (t = -1) or at the same time as forskolin. The C-kinase
kinase inhibitor, Calphostin C (Cal-C; 1 µM), was
added at the same time as forskolin. RNA was isolated 5 h later
and PR mRNA was analyzed by RT-PCR.
|
|
E Does Not Directly Activate the Proximal or Distal
Promoters of the PR Gene in Granulosa Cells
As a complementary approach and more direct way to assess the
specific effects of E, FSH, and LH on transactivation of the PR gene,
we analyzed hormone-induced transactivation of various PR
promoter-reporter constructs. The promoter-reporter constructs used in
this study have been reported to be inducible by E alone and enhanced
by A-kinase activators in other cell types (7, 10) and are shown
schematically in Fig. 5A
. They include
the distal (P) and proximal (P') promoters ligated to the
chloramphenicol acetyltransferase (CAT) reporter gene, as well as
concatamers of an ERE-like region (ERE3) of the proximal promoter or a
consensus ERE from the vitellogenin B1 gene ligated to the distal
promoter (10). As a control, a vector containing two copies of a
consensus ERE ligated to a minimal promoter E1b-CAT construct (ERE-E1b
CAT) was used (32). To verify the function of the ERE3 and ERE regions,
vectors containing either a mutation of ERE3 (ERE3m) or the
minimal E1b-promoter were used. All vectors were transfected into
granulosa cells that had been cultured for 48 h with FSH/T
(i.e. those in which the endogenous PR gene is induced by
forskolin). After 4 h the DNA was removed, and the cells were
stimulated with various agonists and antagonists.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 5. Activation of PR Promoter Constructs by
Forskolin
A, Schematic of the rat PR promoter and the PR promoter-reporter
constructs used in transfection assays. The distal promoter (P; -131
to +65) is GC-rich whereas the putative proximal promoter (P'), which
lies within coding region (+461 to +675), contains an ERE half-site and an ERE-like region, previously
designated ERE3 (7 10 ). The transcriptional start site (+1) as well as
the two translational start sites for PRB and PRA forms of the receptor
are indicated. Distal and proximal promoters were each ligated to the
CAT reporter construct. In addition, concatamers of the ERE3 region
(AGCTTCTCGGGTCGTCATGACTGAGCT) as well as a mutant ERE3
(ERE3m; AGCTTCTCGGGTttTCATGACTGAGCT) have been ligated to
the distal promoter. These vectors have previously been shown to
respond to E in specific cell lines (7 10 ). The ERE-E1b-CAT vector
(kindly provided by Dr. John Cidlowski, NIEHS, Research Triangle Park,
NC) was used as a control for the effects of E and its receptors in
these cells. B, Forskolin inducibility of PR promoter-reporter
constructs in granulosa cells. The constructs described in Fig. 5A were
transiently transfected (see Materials and Methods) into
granulosa cells cultured for 48 h in the presence of FSH (50
ng/ml) and T (10 ng/ml). After transfection, the cells were either
cultured in medium alone or stimulated with forskolin alone or
forskolin in the presence of ICI (as in Fig. 1B ) for 5 h. At that
time the cells were lysed and the lysates analyzed for CAT activity.
Each point represents the mean± SEM using results obtained
in two independent experiments. C, Forskolin but not E activates the
(ERE3)3-P-CAT and ERE-E1b-CAT promoter-reporter constructs. Granulosa
cells were cultured and transfected as above with either (ERE3)3-P-CAT,
mutant (ERE3m)3-P-CAT, ERE-E1b-CAT, or the minimal E1b-CAT vectors.
Cells were then cultured for 5 h in medium alone or in the
presence of E (10 ng/ml), forskolin (FSK; 10 µM), or E
and forskolin with or without ICI 164,384 (500-fold excess). CAT
activity was analyzed in the cell lysates. Similar results were
obtained in three separate experiments.
|
|
The distal promoter-reporter construct exhibited a small but
significant (P < 0.05) increase in CAT activity in
response to forskolin (Fig. 5B
). When three copies of ERE3 [(ERE3)3]
were placed upstream of the distal (P) promoter, forskolin-stimulated
activity was markedly increased (P < 0.001), and
mutation of the ERE3 abolished this response (P <
0.001), indicating that the ERE3 region was essential for mediating
enhanced activation of the distal promoter by cAMP. When a single copy
of the consensus ERE was placed upstream of the distal promoter, a
significant response to forskolin was also observed (P
< 0.05). The proximal promoter-reporter construct containing the ERE3
site showed a response to forskolin (P < 0.05),
whereas the control construct ERE-E1b-CAT containing two copies of the
consensus ER-binding site exhibited a vigorous response to forskolin
(P < 0.001). The addition of the ER antagonist ICI did
not block forskolin-induced activity of the vectors containing
consensus EREs. Although in this experiment ICI did decrease the
forskolin-induced activity of the (ERE3)3-P-CAT, this was not observed
consistently in later experiments (Fig. 5C
) and is presumed to be a
nonspecific effect.
These same constructs were then transfected to analyze their response
to either E or forskolin alone or in combination (Fig. 5C
). E alone
failed to increase the activity of any construct, including the
ERE-E1b-CAT vector. As above, forskolin alone markedly increased
(P < 0.001) the activities of the ERE3-P-CAT and the
ERE-E1b-CAT constructs. The addition of E did not enhance the effects
of forskolin. However, mutation of ERE3 or deletion of the ERE
abolished (P < 0.001) the responses to forskolin in
each vector, indicating that these regions are critical for mediating
the forskolin-induced responses. Lastly, cells were transfected to
determine whether the ER antagonist ICI could block the effect of
forskolin in the presence of E. As shown, the effects of forskolin or
forskolin plus E on the activity of the (ERE3)3-P-CAT and ERE-E1b-CAT
vectors were not inhibited by ICI. Collectively, these results indicate
that an ERE-like region (ERE3) in the PR promoter and the consensus ERE
of the vitellogenin B1 gene are not inducible by exogenous E alone in
granulosa cells. Furthermore, the functional activation of these
regions by cAMP was not reduced by the E antagonist ICI.
An ERE Consensus DNA but Not the ERE-Like Region (ERE3) within the
Promoter of the PR Gene Binds ER Present in Granulosa Cell Nuclear
Extracts
Based on the lack of a functional response to E when the
ERE3- and ERE-containing vectors were transfected into preovulatory
granulosa cells, we next sought to determine the relative amount and
subtype of ER present in the preovulatory granulosa cells. For this,
electrophoretic mobility shift assays (EMSAs) were done using a
consensus ERE oligonucleotide as the labeled DNA probe, specific ER
and ERß antibodies for supershift analyses, and nuclear extracts
prepared from granulosa cells isolated from ovaries of hormonally
primed hypophysectomized (H) rats (33, 34). Different stages of
follicular development were stimulated by treatment with E (HE;
preantral), E and FSH (HEF; preovulatory), and hCG (HEF/hCG; ovulatory)
(4). Whole cell extracts were also prepared from corpora lutea isolated
from ovaries of HEF/hCG-treated rats as well as pregnant rats (35).
When the ERE consensus oligonucleotide was used as the labeled probe
and nuclear extracts from preovulatory granulosa cells (HEF) were
used as the source of protein, one major, diffuse protein/DNA complex
and one minor, closely associated complex were formed (Fig. 6A
). The major, diffuse band was competed
with a 100-fold excess of cold competitor DNA, whereas the smaller band
was not. When antibody to ER
was added to the reactions, only a
small amount of the major complex was supershifted. However, when an
antibody to ERß was added, most of the major complex was supershifted
(Fig. 6A
). Neither antibody altered the migration of the minor band.
This observation, combined with the lack of competition with unlabeled
DNA, indicates that this band is nonspecific.

View larger version (31K):
[in this window]
[in a new window]
|
Figure 6. Consensus ERE but Not ERE3 Binds ER and ERß
Subtypes Present in Ovarian Cells
EMSAs were done using ERE and ERE3 oligonucleotides as described in
Materials and Methods. Nuclear extracts of granulosa cells from H rats before and after treatment with E
(HE), E and FSH (HEF), and hCG (HEF + hCG) as well as whole cell
extracts from corpora lutea of pregnant rats at day 7 or 16 of
gestation were used as indicated. Antibodies to ER , ERß, SF1,
C/EBP , and C/EBPß were used (1 µl) to identify proteins binding
to the DNA. Cold competitor DNA (100-fold molar excess) was also added
to determine specificity of the binding reactions. A, Incubation of
labeled ERE with HEF nuclear extracts resulted in a single band
comprised primarily of ERß with only small amounts of ER as
indicated by the supershifts. B, ERß was equally present in H, HE,
and HEF extracts but decreased in response to hCG. In contrast, ER ,
but not ERß, was present in whole cell extracts of corpora lutea
(CL). C, Proteins binding to labeled ERE3 probe are not ERß or ER
(not shown), SF1, or C/EBP /ß.
|
|
To determine whether the amount of ERß in granulosa cells
changed during follicular development, additional EMSAs were done. A
protein/DNA complex of similar mobility and intensity was observed when
nuclear extracts from granulosa cells of H, HE, and HEF rats were used
in the assays (Fig. 6B
, lanes 24). However, when extracts prepared
from HEF-hCG-treated rats were used, the amount of the major
protein/DNA complex decreased markedly within 4 h and was
undetectable in luteal cell extracts prepared 48 h after hCG (Fig. 6B
, lanes 5 and 6). When whole cell extracts of corpora lutea isolated
on days 7 and 16 of pregnancy were used in the assay, a protein/DNA
complex of similar mobility was formed (Fig. 6B
; lanes 7 and 8). When
antibodies to ERß and ER
were included in the reactions, the ERß
antibody supershifted the complex formed by nuclear extracts of HE
granulosa cells (Fig. 6B
, lane 10) but not the complex formed using
extracts from luteal cells (Fig. 6B
, lane 12). Conversely, the ER
antibody supershifted the entire complex present in luteal tissue but
had only a minor effect in extracts of granulosa
cells (Fig. 6B
, lanes 11 and 9, respectively). Immunofluorescent
analyses of granulosa cells using the same ER antibodies verified high
levels of ERß (but no detectable ER
) in nuclei of granulosa cells
cultured overnight in serum-free medium (data not shown). An antibody
specific for steroidogenic factor-1 (SF1) had no effect on the
protein/DNA complex (data not shown). These results provide the first
evidence that ERß and ER
proteins are present in ovarian cells and
that the relative amount of each receptor subtype changes during
differentiation. Granulosa cells contain an abundance of ERß that is
capable of binding to the ERE consensus, whereas luteal cells contain
ER
.
When a single-copy ERE3 oligonucleotide was used as the labeled
probe, four specific protein/DNA complexes were observed using nuclear
extracts of HEF granulosa cells. These complexes were competed with a
100-fold excess of cold competitor ERE3 DNA (Fig. 6C
). However, neither
the ERß antibody nor the ER
antibody (not shown) shifted the
complexes. This same oligonucleotide also competed very poorly for the
binding of ER to the ERE consensus DNA (10). Antibodies to SF1, which
is capable of binding to an ERE half-site (CAAGGTCA), and antibodies to
the CAAT enhancer-binding proteins (C/EBPß and C/EBP
; used here
for nonspecific binding) also failed to shift the protein/DNA
complexes. Although the ERE3 site has homology to an AP1/CRE binding
site (containing CGTCA), a consensus AP1 oligonucleotide did not
compete, specific antibodies to CREB (c-Jun, Jun B, and Jun D) failed
to supershift the complexes, and purified CREB failed to bind the ERE3
oligonucleotide (data not shown). Mutation of the ERE3 oligonucletoide
at sites that prevented forskolin inducibility of the (ERE3m)3-P-CAT
vector also prevented protein/DNA complex formation (data not shown),
indicating that the nucleotides critical for the protein/DNA
interactions involve those that comprise the putative ERE-like site.
Collectively, these data indicate that proteins other than ER are
interacting with ERE3 to confer forskolin inducibility of the
promoter-reporter constructs. However, the identity of these factors
remains to be determined.
To characterize the proteins binding to the functional region of
the distal PR promoter (21), an oligonucleotide to the GC-rich region
containing putative Sp1 and C/EBP binding sites was synthesized,
labeled, and used as the probe in EMSAs. Using granulosa cell nuclear
extracts, several complexes were observed (Fig. 7
). When antibodies to Sp1, C/EBP
, and
C/EBPß were added to the reactions, only the Sp1 antibody caused a
shift (Fig. 7A
). When additional EMSAs were run using antibodies to
either Sp1, Sp3, or the combination, Sp1 and Sp3 antibodies caused two
of the complexes (denoted by arrows) to shift (denoted by
small arrowheads) indicating that not only Sp1 but also Sp3
is present in granulosa cells and binds to this region of the PR
promoter (Fig. 7B
). Furthermore, recombinant Sp1 bound to this region
and was shifted with the Sp1 but not an Sp3 antibody, indicating the
specificity of the antibodies and their binding activities.
Oligonucleotides containing mutant Sp1 sites did not compete for
binding. Thus, this functional region of the distal PR promoter (Ref.
21 and data herein) binds members of the Sp1 family but does not
bind C/EBP
or C/EBPß that are present in granulosa cell
nuclear extracts (31).

View larger version (44K):
[in this window]
[in a new window]
|
Figure 7. The GC-Rich Region of the Distal Promoter Binds Sp1
and Sp3 but Not C/EBP /ß
HEF nuclear extracts were incubated with labeled oligonucleotide
spanning the functional GC-rich region of the distal promoter (21 ). A,
Antibodies to Sp1, but not C/EBP and C/EBPß, recognize proteins in
the complex. B, Specific complexes are shifted by the Sp1 and Sp3
antibodies. Purified Sp1 also binds the labeled distal probe and is
shifted with Sp1, but not Sp3, antibodies. Arrowheads
indicate the specific supershifted bands.
|
|
 |
DISCUSSION
|
---|
Ovarian granulosa cells have been known for some time to contain
nuclear E-binding proteins (24) and to require E for differentiation
(4). In situ hybridization studies have recently shown that
ERß is the most abundant subtype in these cells (25, 26). The
bandshift assays and immunofluorescent analyses provided herein
document that ERß protein is also selectively expressed in granulosa
cells, whereas levels of ER
protein were much lower. The presence of
these receptors combined with the fact that preovulatory follicles are
the major source of E provide evidence consistent with the notion that
E has a role in the induction of PR in granulosa cells as it does in
other cells (13). Although this hypothesis is attractive, the effects
of E on PR expression in the ovary remain elusive. The studies
conducted herein reinforce the notion that the regulation of PR in
granulosa cells may not be exclusively dependent on the activation of
ER by its ligand. Of note, the induction of PR by LH is temporally
restricted to preovulatory follicles that are already producing E but
in which the LH surge rapidly terminates expression of aromatase (36, 37), biosynthesis of E (38, 39), and levels of ERß protein (figures
herein). Thus, the induction of PR mRNA is occurring in follicles at a
time when follicular levels of E and its receptor are being markedly
reduced. Furthermore, E and specific E antagonists, such as ICI,
exhibit specific temporal effects on PR induction at stages of
granulosa cell differentiation that are distinct from those when PR is
induced by A-kinase activators. Furthermore, vectors containing rat PR
promoters, as well as vectors containing consensus ERE-regulatory
regions, exhibit nonconventional responses to E and A-kinase activators
when transfected into preovulatory granulosa cells. Based on these and
subsequent considerations, we conclude that induction of PR by the LH
surge in preovulatory granulosa cells is complex and that E (and ER)
likely act via an indirect mechanism(s) rather than by a direct
mechanism to activate the PR gene in granulosa cells.
The temporal expression of ERs and the biosynthesis of E provide
evidence favoring an indirect mechanism for E activation of the PR
gene. First, ERß mRNA has been shown to be expressed in follicles of
immature rats (25, 26). Furthermore, we show herein by DNA binding
studies using a consensus ERE oligonucleotide that ERß protein is
present in granulosa cells of H rats before and after treatment with E
and FSH. By immunofluorescent analyses, we show that ERß is localized
to nuclei of granulosa cells before exposure to FSH or E. Thus, if E
could directly activate the PR gene via an ERE-like sequence present in
the PR promoter, E alone would be expected to induce expression of PR
mRNA when added to undifferentiated granulosa cells as well as in
differentiated granulosa cells. However, as shown herein, neither the
addition of E to immature granulosa cells nor the addition of T to
cells expressing aromatase and thereby capable of converting this
androgen to E (28) was effective in inducing PR mRNA in these cells.
Likewise, E alone does not induce PR in granulosa cells of small
preantral follicles in H rats (our unpublished data).
Taken together, these results suggest that neither the presence of
ERß nor the binding of ligand to ERß is sufficient for induction of
PR in granulosa cells. This is not due to a lack of response of these
cells to E. E markedly increases granulosa cell proliferation (38) as
well as an increase in the cell cycle regulator, cyclin D2, in
granulosa cells in vivo (39). E also increases cyclin D2
mRNA in granulosa cells cultured in serum-free medium (39).
The hypothesis that E acts via an indirect mechanism to facilitate LH
induction of PR is further supported by the temporal effects of E.
First, T and E are important for enhancing FSH-mediated attainment of a
preovulatory phenotype (4, 28, 29, 30). E can be added as late as 24 h
of culture and still enhance FSH-mediated granulosa cell
differentiation with subsequent induction of PR mRNA by forskolin.
Second, although the antiestrogen ICI was completely ineffective in
blocking the rapid (within 5 h) induction of PR mRNA by forskolin
in differentiated granulosa cells, it markedly blunted the response to
forskolin if present throughout the 48 h of hormone-dependent
differentiation. These observations are consistent with the notion that
the ability of E (and ER) to alter granulosa cell function is temporal,
specific, and critically dependent on FSH and LH activation of the
A-kinase pathway (4). There is no doubt that E can directly activate ER
function and the expression of some genes in these cells. However, the
acute induction of PR is dependent on more complex interactions
involving a diverse set of putative regulatory elements present in the
promoter of the PR gene. These include a CG-rich distal promoter and
several ERE-like regions present in the distal and proximal
promoters.
The transcriptional activation of various PR promoter-reporter
constructs in granulosa cells also appears to favor an indirect effect
of E and ER on PR induction by LH. Vectors shown to be induced by E in
other cell types (7, 10) showed no response to E alone when transfected
into granulosa cells. Specifically, when E alone was added to granulosa
cells transfected with distal (P) or proximal (P') PR-CAT vectors, no
induction of activity was observed. Ligation of a concatamer of an
ERE-like element (ERE3; Ref. 10) to the distal promoter, (ERE3)3-P-CAT,
also failed to exhibit a response to E in granulosa cells. This is in
marked contrast to the inducibility of (ERE3)3-P-CAT by E alone in MCF7
cells (10). Conversely, in the absence of E, forskolin induced CAT
activity in the (ERE3)3-P-CAT vector, and this activation was lost when
the ERE3 site was mutated. Furthermore, the E antagonist ICI did
not block forskolin-induced activation of the ERE3-P-CAT. These results
indicate that the mechanism by which forskolin induces activation of
these PR promoter constructs occurs independently of E in granulosa
cells.
This evidence indicating that E does not regulate expression of PR
directly is tempered by the unexpected but interesting observation that
E alone fails to activate the ERE-E1b-CAT vector when transfected into
differentiated granulosa cells. Rather this vector was induced by
forskolin alone, and the forskolin-induced activity was not blocked by
addition of ICI. We have shown that the consensus ERE contained within
this construct binds an abundance of ERß present in granulosa cell
extracts as well as ER
present in luteal cells. Thus, the ERE is a
functional DNA-binding site for both ER subtypes in granulosa cells.
These observations indicate that the endogenous ERß may already be
occupied by small amounts of endogenous E and that activation of
ligand-occupied ER in granulosa cells is dependent on a phosphorylation
event. That phosphorylation of some factor within these cells is
critical is highly interesting and supported by the evidence that
activators of A-kinase (LH, forskolin) can induce PR in differentiated
granulosa cells and that the effects of A-kinase are blocked by the
A-kinase inhibitor, H89. Because cycloheximide also blocked induction
of PR, we believe that de novo synthesis of some factor is
also obligatory. The inducible factors remain unknown. They are
unlikely to be the ER subtypes since ERß mRNA (25, 26) and protein
(figures herein) are present in preovulatory granulosa cells and
decrease after exposure to ovulatory levels of LH/hCG. Although we
shown herein that Sp1 and Sp3 bind to the distal promoter, these
factors are not hormonally regulated in granulosa cells (40). Rather,
they are expressed at elevated levels during follicular
development and in corpora lutea (40). Although C/EBPß was a likely
candidate to be the LH-inducible factor (31), we could not detect
binding of C/EBPß to the GC-rich region of the distal PR promoter
that has been shown herein and elsewhere to be regulated by cAMP (21).
Furthermore, the distal region by itself gave only a marginal response
to LH. Therefore, it would appear that factors binding to the distal
region (Sp1/Sp3) must interact with factors binding to the ERE3 site to
confer maximal activity.
Activators of A-kinase may lead to the phosphorylation of a specific
coactivator or another transcription factor obligatory for the
induction of PR. CBP and SRC-1 both are capable of being phosphorylated
by A-kinase (41, 42). Therefore, the function of ER bound to an ERE
site or another site may be dependent on the phosphorylation of these
or related coactivators. In addition, we show herein that Sp1/Sp3 is
present in granulosa cell extracts and bind to the GC-rich region of
the distal promoter of the PR gene. Sp1/Sp3 have recently been shown to
be expressed at high levels in granulosa cells and to confer cAMP
inducibility to a number of genes expressed in ovarian cells (40).
These include the serum and glucocorticoid-inducible kinase, Sgk (40);
cholesterol side-chain cleavage cytochrome P450, P450scc (43); and the
cell cycle-inhibitory protein, p21CIP (44). Because a
single copy of the consensus ERE and three copies of ERE3 enhanced
expression of the distal promoter, it is attractive to postulate that
the Sp1/Sp3-binding site in the distal promoter needs to interact with
additional, adjacent regulatory mechanisms to confer cAMP inducibility
to the promoter. Most recently, ER has been shown to bind to Sp1 and
increase its DNA and transactivation potential in the absence of an ER
DNA-binding site (45). Thus, one explanation that combines a role for
ER and A-kinase on the PR promoter would be that ER binds Sp1 and that
A-kinase phosphorylates either one of these factors or an additional
coactivator or coregulator (CBP?) to enhance transcription.
These observations raise an intriguing question: Of what physiological
significance is the obligatory requirement of A-kinase
(phosphorylation?) for activation of putative ER-regulated genes in
ovarian cells? The absence of a direct effect of E on genes, such as
PR, in granulosa cells may have evolved to ensure that PR is not
induced prematurely in the E-producing, estrogen-enriched milieu of the
preovulatory follicle. Rather, induction of PR may only occur when E
coming from the preovulatory follicle elicits the LH surge. If the
ERE-like regions in the PR promoter bind AP1-related factors, this may
be particularly relevant. Recent studies have shown that in the
presence of E or diethylstilbestrol, the ERß subtype is a
negative regulator of ER action via AP1-responsive elements (46).
Conversely, antiestrogens are positive regulators in these same vectors
(46). Thus, in the developing follicle, ERß may inhibit ER action in
promoters with AP1 response elements while favoring activation of
promoters with EREs. A secondary level of control may involve the level
and sites of phosphorylation of ER. The effect of the LH surge may also
be to shift the balance from the predominantly ERß granulosa cell to
the ER
-containing luteal cell. ER
, unlike ERß, can enhance
activity on the AP1 regions in the presence of E or antiestrogens (46).
Alternatively, recent studies have shown that ER can facilitate the
functional activity of Sp1 (45). Thus, phosphorylation of Sp1 or ER may
be required for their interactions, and this may occur independently of
E. ERß may exert specific and critical functions in tissues that
express aromatase and have high endogenous levels of E. Collectively,
the results of this study indicate that activation of the A-kinase
pathway leads to the phosphorylation of some transcription factor(s)
other than, or in addition to, ER that is (are) essential for
transactivation of the PR gene and that this mechanism is selectively
activated in granulosa cells of preovulatory follicles.
 |
MATERIALS AND METHODS
|
---|
Reagents
Media and cell culture reagents and materials were purchased
from GIBCO (Grand Island, NY), Sigma (St. Louis, MO), Research Organics
(Cleveland, OH), Fisher Scientific (Fairlawn, NJ) Corning (Corning, NY)
and Hyclone (Logan UT). Trypsin, soybean trypsin inhibitor,
deoxyribonuclease (DNAse), PMA, E, propylene glycol, and mineral oil
were all purchased from Sigma. Ovine FSH (oFSH-16) and LH (oLH-23) were
gifts of the National Hormone and Pituitary Program (Rockville, MD).
Human CG (hCG) was from Organon Special Chemicals (West Orange, NJ).
GnRH, Calphostin C, and Nonidet-40 (NP-40) were obtained from
Calbiochem (La Jolla, CA). ICI 164,384 was provided by Dr. Alan
Wakeling (Zeneca Pharmaceuticals, Macclesfield, UK). Cycloheximide was
purchased form Nutritional Biochemicals (Cleveland, OH); H89 was
acquired from Seigagaku America (Rockville, MD); T and E for tissue
culture were purchased from Steraloids (Keene, NH). Bryostatin was
provided by Dr. Alan Fields (Case Western Reserve University,
Cleveland, OH). Electrophoresis and molecular biology grade reagents
were purchased from Sigma, Bio-Rad (Richmond, CA), and Boehringer
Mannheim Biochemicals (Indianapolis, IN). Oligonucleotides were
purchased from Genosys (The Woodlands, TX). All RT-PCR reagents were
from Promega (Madison, WI) except for deoxyribonucleotides (dNTPs;
Boehringer Mannheim).
-32P[dCTP] was from ICN
Radiochemicals (Costa Mesa, CA). Hyperfilm was purchased from Amersham
(Arlington Heights, IL). [C14]chloramphenicol was
purchased from Amersham, and acetyl coenzyme A was obtained from
Pharmacia (Piscataway, NJ).
Animals
Intact and hypophysectomized immature (day 25 of age) Holtzman
Sprague-Dawley female rats (Harlan, Indianapolis, IN) were housed under
a 16-h light, 8-h dark schedule in the Center for Comparative Medicine
at Baylor College of Medicine (Houston, TX) and provided food and water
ad libitum. Animals were treated in accordance with the NIH
Guide for the Care and Use of Laboratory Animals, as approved by the
Animal Care and Use Committee at Baylor College of Medicine.
Granulosa Cell Cultures
Granulosa cells were harvested from untreated immature rats or
from E-primed rats as previously described (27, 28) and as indicated in
Results and figure legends. Cells were cultured at a density
of 1 x 106 cells per 3 ml serum free medium (DMEM:F12
containing penicillin and streptomycin) in multiwell (35-mm) dishes
that were serum coated. Hormones, agonists, antagonists, and inhibitors
were added as indicated in the figure legends.
RNA Isolation and RT-PCR Assays
Cytoplasmic RNA was isolated from cultured cells with a buffer
containing 1% NP-40 (28). Each RNA sample was pooled from three
replicate wells. The RNA was purified by sequential phenol,
phenol-chloroform, and chloroform extraction, followed by ethanol
precipitation. The RNA was resuspended in 0.1%
diethylpyrocarbamate-treated water, and its concentration was
determined by absorbance at 260 nm.
RT-PCR reactions were performed as previously described (47) using
specific primer pairs for rat PR (forward, 5'-CCCACAGGAGTTTGTCAAGCT-3'
and reverse 5'-TAACTTCAGACATCATTCCGG-3') (1, 6) and the ribosomal
protein L19 (1, 6). The amplified cDNA products were resolved by
acrylamide gel electrophoresis, and radioactivity/PCR product band was
quantified on a Betascope 603 Blot Analyzer (Betagen Corp., Mountain
View, CA). Data are presented as the ratio of radioactivity in the PR
and L19 bands.
Transfections
The rat PR promoter-CAT reporter constructs analyzed in these
studies have been used previously in other cell types (7, 10) and are
shown in Fig. 6
. For transfections, granulosa cells were harvested from
E-primed immature rats and cultured in the presence of FSH (50 ng/ml)
and T (10 ng/ml) for 48 h, conditions that permit transactivation
of the endogenous PR gene by hormones and forskolin (2, 4). The cells
were transiently transfected using 4.78 pmol plasmid/well and the
calcium phosphate precipitation method (33, 34). Four hours later, the
DNA was removed, and the cells were washed and cultured in the presence
or absence of 7.5 µM forskolin for 5 h. At that
time, the cells were lysed by freeze-thaw procedure, and cytosolic
protein concentrations were determined by the mini-Bradford assay
(Bio-Rad). CAT activity in the extracts was analyzed using 30 µg
protein and an 18-h incubation according to a standard protocol (33, 34). The amount of radioactivity in the substrate and acetylated
products after chromatographic separation was determined by the
Betascope 603 Blot Analyzer. Transfections of each plasmid were done in
triplicate, and at least three replicate experiments were
performed. Data are expressed as the mean ± SEM.
EMSAs
Oligonucleotides to specific regions of the PR promoter were
synthesized, annealed, and labeled according to routine procedures (33, 34). The double-stranded oligonucleotides included:
1. The GC-rich region of the distal promoter (Distal:
5'-AGGTCTAGCCAGTGATTGGCTAGGGAGGGGCTTTGGGCGGGCCTTCCTAGAGC
and reverse
AGGGCTCTAGGAAGGCCCGCCCAAAGCCCTCCCTAGCCAATCACTGGCTAGA);
2. The ERE3 region of the proximal promoter (ERE3:
5'-AGGTCTCGGGTCGTCATGACTGAGCT and reverse AGGAGCTCAGTCATGACGACCCGAGA as
well as
3. An ERE consensus from the vitellogenin B1 gene (EREcon:
5'-AGGCAAAGTCAGGTCACAGTGACCTGATCAAAGA and reverse
AGGTCTTTGATCAGGTCACTGTGACCTGACTTTG.
Oligonucleotides were incubated with nuclear extracts or whole cell
extracts prepared from granulosa cells of hypophysectomized (H) rats
treated sequentially with E (HE), FSH (HEF), and hCG (HEF + hCG) as
previously described (33, 34, 35). Extracts were also prepared from corpora
lutea isolated from the ovaries of pregant rats on days 7 and 16 of
gestation. After 20 min at room temperature, the binding reactions were
subjected to nondenaturing electrophoresis (0.5% Tris-borate-EDTA) at
150 V. Where indicated, specific antibodies against nuclear proteins
were added to the reactions for 30 min on ice before the addition of
labeled DNA. The antibodies used were specific for ER
(Santa Cruz
Biotechnology, Santa Cruz, CA) and ERß (Affinity Bioreagents, Golden,
CO), c-fos (Oncogene Science Inc, Manhasset, NY),
pan-Jun (Oncogene), SF1 (Dr. Ken Morohashi, National Institute for
Basic Biology, Okazaki, Japan), CAAT enhancer binding proteins,
C/EBP
and C/EBPß (Dr. Valerie Poli, Instituto di Ricerche, Rome,
Italy), and stimulatory proteins, Sp1 and Sp3 (Promega, Madison,
WI).
Immunocytochemistry
Granulosa cells from E-primed immature rats were cultured as
above on glass coverslips for varying times in the presence or absence
of FSH or forskolin. Cells were processed for immunocytochemistry as
described previously (33). Briefly, cells were fixed in fresh 4%
paraformaldehyde (Electron Microscopy Sciences, Fort Washington, PA) in
PBS for 30 min at room temperature, washed in 10 mM glycine
in PBS and PBS. The fixed cells were either stored at 4 C. The
cells were permeabilized with 0.5% NP-40 in PBS for 10 min and then
blocked with 4% BSA in PBS for 1 h at room temperature. The cells
were incubated at 4 C for 18 h with specific antibodies diluted
1:500 in 4% BSA in PBS. After several PBS washes, cells were incubated
with flourescein-labeled goat anti-rabbit IgG (1:20, Pierce, Rockford,
IL) in 4% BSA in PBS for 1 h at room temperature. ERß and ER
were visualized on a Zeiss Axiophot microscope (Carl Zeiss, Thornwood,
NY).
Statistical Analyses
RT-PCR and transfection data were analyzed by ANOVA. Values
represent the mean ± SEM for at least three
experiments and were considered significantly different if
P < 0.05.
 |
FOOTNOTES
|
---|
Address requests for reprints to: JoAnne S. Richards, Department of Cell Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030. E-mail: joanner{at}bcm.tmc.edu
Supported in part by NIH Grants HD-16229 (J.S.R.) and CA-18119 and US
Army Grant DAMD-17-J-4205 (B.S.K.).
1 Current address: Department of Biological Sciences, Duquesne
University, Pittsburg, Pennsylvania 15282. 
2 Current address: Department of Biology, University of California San
Diego, La Jolla, California 92093. 
Received for publication February 18, 1998.
Revision received April 15, 1998.
Accepted for publication April 30, 1998.
 |
REFERENCES
|
---|
-
Park O-K, Mayo K 1991 Transient expression of
progesterone receptor messenger RNA in ovarian granulosa cells after
the preovulatory luteinizing hormone surge. Mol Endocrinol 5:967978[Abstract]
-
Natraj U, Richards JS 1993 Hormonal regulation, localization
and functional activity of the progesterone receptor in granulosa cells
of rat preovulatory follicles. Endocrinology 133:761769[Abstract]
-
Lydon JP, De Mayo F, Funk CR, Mani SK, Hughes AR, Montgomery
CA, Shyamala G, Conneely OM, OMalley BW 1995 Mice lacking
progesterone receptor exhibit reproductive abnormalities. Genes Dev 9:22662278[Abstract]
-
Richards JS 1994 Hormonal control of gene expression in the
ovary. Endocr Rev 15:725751[Medline]
-
Schrader WT, OMalley BW 1972 Progesterone-binding
components of chick oviduct. IV. Characterization of purified subunits.
J Biol Chem 247:5159[Abstract/Free Full Text]
-
Park-Sarge O-K, Parmer TG, Gibori G 1995 Does the rat corpus
luteum express the progesterone receptor gene? Endocrinology 136:15371543[Abstract]
-
Kraus WL, Montano MM, Katzenellenbogen BS 1993 Cloning of the
rat progesterone receptor gene 5'-region and identification of two
functionally distinct promoters. Mol Endocrinol 7:16031616[Abstract]
-
Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer
H, Chambon P 1990 Two distinct estrogen-regulated promoters generate
transcripts encoding the two functionally different human progesterone
receptor forms A and B EMBO J 9:16031614[Abstract]
-
Misrahi M, Loosfelt H, Atger M, Meriel C, Zerah V, Dessen P
Milgrom E 1988 Organization of the entire rabbit progesterone receptor
mRNA and of the promoter and 5' flanking region of the gene.
Nucleic Acids Res 16:54595472[Abstract]
-
Kraus WL, Montano MM, Katzenellenbogen BS 1994 Identification
of multiple, widely spaced estrogen-responsive regions in the rat
progesterone receptor gene. Mol Endocrinol 8:952969[Abstract]
-
Tung L, Mohamed MK, Hoeffler JP, Takimoto GS, Horwitz KB 1993 Antagonist-occupied human progesterone B-receptors activate
transcription without binding to progesterone response elements and are
dominantly inhibited by A-receptors. Mol Endocrinol 7:12561265[Abstract]
-
Vegeto E, Shahbaz MM, Wen DX, Goldman ME, OMalley BW,
McDonnell DP 1993 Human progesterone receptor A form is cell and
promoter-specific repressor of human progesterone receptor B function.
Mol Endocrinol 7:12441255[Abstract]
-
Clark JH, Mani SK 1994 Actions of ovarian steroid hormones,
In: Knobil E, Neill JD (eds) The Physiology of Reproduction. Raven
Press, New York, pp 10111059
-
Espey LL, Lipner H 1994 Ovulation. In: Knobil E, Neill JD
(eds) The Physiology of Reproduction, ed. 2. Raven Press, New York, pp
725780
-
Espey LL 1980 Ovulation as an inflammatory reaction a
hypothesis. Biol Reprod 22:73106[Medline]
-
Schott DR, Shyamala G, Schneider W, Parry G 1991 Molecular
cloning, sequence analysis and expression of complementary DNA encoding
murine progesterone receptor. Biochemistry 30:70147020[Medline]
-
Chang T-C, Nardulli AM, Lew D, Shapiro DJ 1992 the role of
estrogen response elements in expression of the Xenopus
laevis vitellogenin B1 gene. Mol Endocrinol 6:346354[Abstract]
-
Ince BA, Montano MM, Katzenellenbogen BS 1994 Activation of
transcriptionally inactive human estrogen receptors by cyclic
adenosine 3',5'-monophosphate and ligands including anitestrogens.
Mol Endocrinol 8:13971406[Abstract]
-
Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H,
Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P 1995 Activation of the estrogen receptor through phosphorylation by
mitogen-activated protein kinase. Science 270:14911494[Abstract]
-
El-Tanani MKK, Green CD 1997 Two separate mechanisms for
ligand-independent activation of the estrogen receptor. Mol Endocrinol 11:928937[Abstract/Free Full Text]
-
Park-Sarge O-K, Sarge KD 1995 Cis-regulatory elements
conferring cyclic 3',5'-adenosine monophosphate responsiveness of the
progesterone receptor in transfected rat granulosa cells. Endocrinology 136:54305437[Abstract]
-
Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin
S-C, Heyman RA, Rose DW, Glass CK, Rosenfeld MG 1996 A CBP integrator
complex mediates transcriptional activation and AP-1 inhibition by
nuclear receptors. Cell 85:403414[Medline]
-
Smith CL, Onate SA, Tsai M-J, OMalley BW 1996 CREB binding
protein act synergistically with steroid receptor coactivator-1 to
enhance steroid receptor-dependent transcription. Proc Natl Acad Sci
USA 93:88848888[Abstract/Free Full Text]
-
Richards JS 1975 Estradiol receptor content in rat
granulosa cells during follicular development:modification by
estradiol and gonadotropins. Endocrinology 97:11741184[Abstract]
-
Kuiper GGM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson
J-A 1996 Cloning of a novel estrogen receptor expressed in rat prostate
and ovary. Proc Natl Acad Sci USA 93:59255930[Abstract/Free Full Text]
-
Byers M, Kuiper GGJM, Gustafsson J-A, Park-Sarge O-K 1997 Estrogen receptor-ß mRNA expression in rat ovary:down regulation by
gonadotropins. Mol Endocrinol 11:172182[Abstract/Free Full Text]
-
Ratoosh SL, Lifka J, Hedin L, Jahnsen T, Richards JS (1987)
Hormonal regulation of the synthesis and m RNA content of the
regulatory subunit of cyclic AMP-dependent protein kinase type II in
cultured granulosa cells. J Biol Chem 262:73067313
-
Fitzpatrick SL, Richards JS (1991) Regulation of cytochrome P
450 aromatase messenger ribonucleic acid and activity by steroids and
gonadotropins in rat granulosa cells. Endocrinology 129:14521462
-
Segaloff DL, Wang H, Richards JS 1990 Hormonal regulation of
LH/CG receptor mRNA in rat ovarian cells during follicular development
and luteinization. Mol Endocrinol 4:18561865[Abstract]
-
Sirois J, Simmons DL, Richards JS 1992 Hormonal regulation of
messenger ribonucleic acid encoding a novel isoform of prostaglandin
endoperoxide H synthase in rat preovulatory follicles. J Biol Chem 267:1158611592[Abstract/Free Full Text]
-
Sirois J, Levy LO, Simmons DL, Richards JS 1993 Characterization and hormonal regulation of the promoter of the rat
prostaglandin endoperoxide synthase 2 gene in granulosa cells. J
Biol Chem 286:121991220
-
Smith CL, Onate SA, Tsai M-J, OMalley BW 1996 CREB binding
protein acts synergistically with steroid receptor coactivator-1 to
enhance steroid receptor-dependent transcription. Proc Natl Acad Sci
USA 93:88848888[Abstract/Free Full Text]
-
Carlone DL, Richards JS 1997 Functional interactions,
phosphorylation and levels of 3',5'-cyclic adenosine
monophosphate-regulatory element binding protein and steroidogenic
factor-1 mediate hormone-regulated and constitutive expression of
aromatase in gonadal cells. Mol Endocrinol 11:292304[Abstract/Free Full Text]
-
Fitzpatrick SL, Richards JS 1994 Identification of a cyclic
adenosine 3',5'-monophosphate response element in the rat aromatase
promoter that is required for transcriptional activation in rat
granulosa cells and R2C Leydig cells. Mol Endocrinol 8:13091319[Abstract]
-
Russell DL, Norman RL, Dajee M, Liu X, Henninghausen L,
Richards JS 1996 Prolactin-induced activation and binding of Stat
proteins to the IL-6RE of the
2-macroglobulin (
2M) promoter in
the rat ovary. Biol Reprod 55:10291038[Abstract]
-
Hickey GJ, Chen S, Besman MJ, Shively JE, Hall PF,
Gaddy-Kurten D, Richards JS 1988 Hormonal regulation, tissue
distribution and content of aromatase cytochrome P 450 messenger
ribonucleic acid and enzyme activity in rat ovarian follicles and
corpora lutea: relationship to estradiol biosynthesis. Endocrinology 122:14261436[Abstract]
-
Fitzpatrick SL, Carlone DL, Robker RL, Richards JS 1997 Expression of aromatase in the ovary:down-regulation of mRNA by the
ovulatory luteinizing hormone surge. Steroids 62:197206[CrossRef][Medline]
-
Rao MC, Midgley Jr AR, Richards JS 1978 Hormonal regulation of
ovarian cellular proliferation. Cell 14:7178[Medline]
-
Robker RL, Richards JS 1998 Hormone-induced proliferation and
differentiation of granulosa cells: a coordinated balance of the cell
cycle regulators cyclin D2 and p27KIP1. Mol Endocrinol 12:924940[Abstract/Free Full Text]
-
Alliston T, Richards JS 1997 Hormonal regulation of serum and
glucocorticoid regulated kinase, Sgk, in rat granulosa cells: role of
Sp1 in FSH action. Mol Endocrinol 11:19341949[Abstract/Free Full Text]
-
Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin
S-C, Heyman RA, Rose DW, Glass CK, Rosenfeld MG 1996 A CBP integrator
complex mediates transcriptional activation and AP-1 inhibition by
nuclear receptors. Cell 85:403414[Medline]
-
Rowan BG, Weigel NL, OMalley BW, Phosphorylation of chicken
progesterone receptor and steroid receptor coactivator-1 during
ligand-independent activation by 8-bromo-cAMP. Program of the 79th
Annual Meeting of The Endocrine Society, Minneapolis MN, 1997 (Abstract
OR235)
-
Liu A, Simpson ER 1997 Steroidogenic factor 1 and Sp1 are
required for regulation of bovine CYP11A gene expression in bovine
luteal cells and adrenal Y1 cells. Mol Endocrinol 11:127137[Abstract/Free Full Text]
-
Prowse DM, Bolgan L, Molnar, Dotto GP 1997 Involvement of the
Sp3 transcription factor in induction of p21CIP1/KIP1 in keratinocyte
differentiation. J Biol Chem 272:13081314[Abstract/Free Full Text]
-
Porter W, Saville B, Hoivik D, Safe S 1997 Functional synergy
between the transcription factor Sp1 and the estrogen receptor. Mol
Endocrinol 11:15691580[Abstract/Free Full Text]
-
Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-A,
Kushner PJ, Scanlan TS 1997 Differential ligand activation of estrogen
receptors ER
and ERß at AP1 sites. Science 277:15081510[Abstract/Free Full Text]
-
Orly J, Rei Z, Greenberg N, Richards JS 1994 Tyrosine kinase
inhibitor AG18 arrests follicle-stimulating hormone-induced granulosa
cell differentiation: use of reverse transcriptase-polymerase chain
reaction assay for multiple messenger ribonucleic acids. Endocrinology 134:23362346[Abstract]